Logo do repositório
 

Breast Cancer Targeting of a Drug Delivery System through Postsynthetic Modification of Curcumin@N3-bio-MOF-100 via Click Chemistry

dc.contributor.authorAlves, Renata C. [UNESP]
dc.contributor.authorSchulte, Zachary M.
dc.contributor.authorLuiz, Marcela T.
dc.contributor.authorBento Da Silva, Patrícia
dc.contributor.authorFrem, Regina C. G. [UNESP]
dc.contributor.authorRosi, Nathaniel L.
dc.contributor.authorChorilli, Marlus [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)
dc.contributor.institutionUniversity of Pittsburgh
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionUniversity of Brasilia (UnB)
dc.date.accessioned2022-04-29T08:30:01Z
dc.date.available2022-04-29T08:30:01Z
dc.date.issued2021-08-16
dc.description.abstractMetal-organic frameworks (MOFs) offer many opportunities for applications across biology and medicine. Their wide range of chemical composition makes toxicologically acceptable formulation possible, and their high level of functionality enables possible applications as delivery systems for therapeutics agents. Surface modifications have been used in drug delivery systems to minimize their interaction with the bulk, improving their specificity as targeted carriers. Herein, we discuss a strategy to achieve a tumor-targeting drug-loaded MOF using clickchemistry to anchor functional folic acid (FA) molecules on the surface of N3-bio-MOF-100. Using curcumin (CCM) as an anticancer drug, we observed drug loading encapsulation efficiencies (DLEs) of 24.02 and 25.64% after soaking N3-bio-MOF-100 in CCM solutions for 1 day and 3 days, respectively. The success of postsynthetic modification of FA was confirmed by 1H NMR spectroscopy, Fourier transform infrared spectroscopy (FTIR), and liquid chromatography-mass spectrometry (LC-MS). The stimuli-responsive drug release studies demonstrated an increase of CCM released under acidic microenvironments. Moreover, the cell viability assay was performed on the 4T1 (breast cancer) cell line in the presence of CCM@N3-bio-MOF-100 and CCM@N3-bio-MOF-100/FA carriers to confirm its biological compatibility. In addition, a cellular uptake study was conducted to evaluate the targeting of tumor cells.en
dc.description.affiliationDepartment of Drugs and Medicines School of Pharmaceutical Sciences of São Paulo State University (UNESP), Rodovia Araraquara Jau, Km 01-s/n-Campos Ville São Paulo
dc.description.affiliationDepartment of Chemistry University of Pittsburgh, 219 Parkman Avenue
dc.description.affiliationDepartment of Pharmaceutical Sciences School of Pharmaceutical Science of Ribeirão Preto University of São Paulo (USP), Avenida do Café, s/n-Campus da USP Sao Paulo
dc.description.affiliationDepartment of Genetics and Morphology Institute of Biological Sciences University of Brasilia (UnB) Campus Universitario Darcy Ribeiro-Asa Norte, Federal District
dc.description.affiliationInstitute of Chemistry São Paulo State University (UNESP), Prof. Francisco Degni 55, PO Box 355 São Paulo
dc.description.affiliationUnespDepartment of Drugs and Medicines School of Pharmaceutical Sciences of São Paulo State University (UNESP), Rodovia Araraquara Jau, Km 01-s/n-Campos Ville São Paulo
dc.description.affiliationUnespInstitute of Chemistry São Paulo State University (UNESP), Prof. Francisco Degni 55, PO Box 355 São Paulo
dc.format.extent11739-11744
dc.identifierhttp://dx.doi.org/10.1021/acs.inorgchem.1c00538
dc.identifier.citationInorganic Chemistry, v. 60, n. 16, p. 11739-11744, 2021.
dc.identifier.doi10.1021/acs.inorgchem.1c00538
dc.identifier.issn1520-510X
dc.identifier.issn0020-1669
dc.identifier.scopus2-s2.0-85108539003
dc.identifier.urihttp://hdl.handle.net/11449/229028
dc.language.isoeng
dc.relation.ispartofInorganic Chemistry
dc.sourceScopus
dc.titleBreast Cancer Targeting of a Drug Delivery System through Postsynthetic Modification of Curcumin@N3-bio-MOF-100 via Click Chemistryen
dc.typeArtigopt
dspace.entity.typePublication
relation.isDepartmentOfPublicatione214da1b-9929-4ae9-b8fd-655e9bfeda4b
relation.isDepartmentOfPublication.latestForDiscoverye214da1b-9929-4ae9-b8fd-655e9bfeda4b
unesp.author.orcid0000-0002-2901-8779[1]
unesp.author.orcid0000-0001-8025-8906[6]
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos